Kyntra Bio (KYNB) Gross Profit (2018 - 2026)
Kyntra Bio (KYNB) posted Gross Profit of $1.47 million for Q2 2026, up 16.5% from $1.26 million a year earlier.
Powered by 
Analysis
Kyntra Bio (KYNB) Gross Profit (2018 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Gross Profit at Kyntra Bio was $3.12 million, down 75.6% year-over-year; for FY2025, it came in at $5.88 million, down 58.2% from FY2024.
- Annual Gross Profit has declined for four consecutive years, with a five-year compound annual growth rate of -48.8% (FY2020 to FY2025).
- In prior years, Kyntra Bio's Gross Profit was $14.06 million in FY2024 (-67.2%), $42.84 million in FY2023 (-64.4%), $120.45 million in FY2022 (-45.8%) and $222.44 million in FY2021 (+32.8%).
- The Q2 2026 figure stands as the highest quarterly Gross Profit since Q1 2025.
- On a year-over-year basis, Gross Profit increased in two of the last five quarters, with an average decline of 32.6%.
- The strongest year-over-year quarter for Gross Profit in the past five years was Q3 2021, with growth of 265.1%; the weakest was Q3 2024, with a decline of 99.9%.
- According to Business Quant data, Gross Profit for the three prior quarters was -$368,000 (Q1 2026), $999,000 (Q4 2025) and $1.02 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn |
| 10 | Kyntra Bio | 18.66 Mn | -389.28 Mn | 1.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.47 Mn |
| Mar 31, 2026 | -368,000.00 |
| Dec 31, 2025 | 999,000.00 |
| Sep 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 1.26 Mn |
| Mar 31, 2025 | 2.49 Mn |
| Dec 31, 2024 | 8.98 Mn |
| Sep 30, 2024 | 48,000.00 |
| Jun 30, 2024 | 858,000.00 |
| Mar 31, 2024 | 4.02 Mn |
| Dec 31, 2023 | -64.33 Mn |
| Sep 30, 2023 | 35.89 Mn |
| Jun 30, 2023 | 38.61 Mn |
| Mar 31, 2023 | 32.67 Mn |
| Dec 31, 2022 | 29.44 Mn |
| Sep 30, 2022 | 11.43 Mn |
| Jun 30, 2022 | 23.00 Mn |
| Mar 31, 2022 | 56.59 Mn |
| Dec 31, 2021 | 13.42 Mn |
| Sep 30, 2021 | 152.71 Mn |
API Access
Kyntra Bio Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=KYNB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "KYNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=KYNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();